Original Research ARTICLE
South Indian Isolates of the Fusarium solani Species Complex From Clinical and Environmental Samples: Identification, Antifungal Susceptibilities, and Virulence
- 1MTA-SZTE “Lendület” Fungal Pathogenicity Mechanisms Research Group, Szeged, Hungary
- 2Department of Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary
- 3Division of Molecular Biology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria
- 4Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Coimbatore, India
- 5Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Majmaah, Saudi Arabia
- 6Greenlink Analytical and Research Laboratory India Private Limited, Coimbatore, India
- 7Department of Genetics, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary
Members of the Fusarium solani species complex (FSSC) are the most frequently isolated fusaria from soil. Moreover, this complex solely affects more than 100 plant genera, and is also one of the major opportunistic human pathogenic filamentous fungi, being responsible for approximately two-third of fusariosis cases. Mycotic keratitis due to Fusarium species is among the leading causes of visual impairment and blindness in South India, but its management is still challenging due to the poor susceptibility of the isolates to conventional antifungal drugs. Aims of the present study were to isolate South Indian clinical and environmental FSSC strains and identify them to species level, to determine the actual trends in their susceptibilities to antifungal therapeutic drugs and to compare the virulence of clinical and environmental FSSC members. Based on the partial sequences of the translation elongation factor 1α gene, the majority of the isolates—both from keratomycosis and environment—were confirmed as F. falciforme, followed by F. keratoplasticum and F. solani sensu stricto. In vitro antifungal susceptibilities to commonly used azole, allylamine and polyene antifungals were determined by the CLSI M38-A2 broth microdilution method. The first generation triazoles, fluconazole and itraconazole proved to be ineffective against all isolates tested. This phenomenon has already been described before, as fusaria are intrinsically resistant to them. However, our results indicated that despite the intensive agricultural use of azole compounds, fusaria have not developed resistance against the imidazole class of antifungals. In order to compare the virulence of different FSSC species from clinical and environmental sources, a Drosophila melanogaster model was used. MyD88 mutant flies having impaired immune responses were highly susceptible to all the examined fusaria. In wild-type flies, one F. falciforme and two F. keratoplasticum strains also reduced the survival significantly. Pathogenicity seemed to be independent from the origin of the isolates.
The genus Fusarium is a large group of hyaline filamentous fungi firstly described by Link (1809). According to the recent literature, it comprises approximately 200–300 species belonging to 20–22 species complexes (O'Donnell et al., 2013, 2015; Al-Hatmi et al., 2016). Fusaria are common soil saprophytes; however, they are also known as phytopathogens (Coleman, 2016). Two Fusarium species were recently included in the list of the top ten plant pathogenic fungi with both economic and scientific importance (Dean et al., 2012). The members of this genus may also interact with plants as endophytic root colonizers (Bacon and Yates, 2006); furthermore, they may be responsible for a wide range of human infections in either immunocompetent or immunocompromised patients (Garnica and Nucci, 2013). In accordance with the current species complex descriptions, at least ten of them have been reported to have human pathogenic representatives (Al-Hatmi et al., 2016). Last but not least, plumbing systems are also proven environmental reservoirs of human-pathogenic Fusarium species (Short et al., 2011).
Taxonomy of the genus Fusarium is changing intensely since 2011, when the era of the dual nomenclature ended (Hawksworth et al., 2011) and a comprehensive phylogenetic study of the genus discovered that the traditionally known Fusarium is not monophyletic (Gräfenhan et al., 2011). Based on these results, Gräfenhan et al. (2011) proposed to restrict the name Fusarium to the Gibberella clade and at the same time to reallocate the medically important Fusarium solani species complex (FSSC) and Fusarium dimerum species complex (FDSC) to other genera. After the release of this study, Lombard et al. (2015) were the first who suggested to use Neocosmospora solani instead of F. solani, and Neocosmospora falciformis instead of F. falciforme. However, in this study we would like to follow a previously published proposal of Geiser et al. (2013) by keeping the historical concept of Fusarium and use the names well-known in medical mycology.
In South India, a frequent scenario of fungal keratitis (keratomycosis) is that agricultural workers are infected after a corneal injury caused by plant or soil materials during their regular activities (Dóczi et al., 2004; Homa et al., 2013). Based on the recent reports, Fusarium species—and among them the members of the FSSC—are the most frequently isolated causative agents of fungal keratitis in this region (Chakrabarti and Singh, 2011; Homa et al., 2013; Hassan et al., 2016). The FSSC comprises at least 60 haplotypes, out of which 22 have been reported to have clinical associations (van Diepeningen et al., 2014; Al-Hatmi et al., 2016) with poor susceptibility to commonly used antifungal drugs (Azor et al., 2007). As consequence of the narrow range of therapeutic options, the treatment of Fusarium keratitis is extremely challenging and the lack of a prompt and effective therapy often results in corneal opacification or complete blindness (Shukla et al., 2008). Therefore, the rapid identification of the causative agent and the determination of its antifungal susceptibility are essential to choose the best therapeutic option. Presumably, the intensive agricultural and clinical (mis)use of antifungal compounds have also influenced the current susceptibility profile of the genus (Al-Hatmi et al., 2016). Thus, besides clinical studies, it is also crucial to evaluate the development of antifungal resistance among environmental strains to follow up the impact of fungicides used in the field.
Among FSSC species, F. falciforme was the most prevalent species isolated from human mycotic keratitis in South India (Homa et al., 2013; Hassan et al., 2016; Tupaki-Sreepurna et al., 2017a,b). However, it is unclear what lies in the background of its dominance: its environmental frequency or its high virulence. FSSC is reported to be more virulent than other species complexes of the genus (Mayayo et al., 1999); however, the virulence of different FSSC species has not been compared before. To answer the questions above, virulence studies are inevitable.
The objectives of the present study were (I) to isolate FSSC strains from keratomycosis patients, agricultural source and natural environments in South India; (II) to identify the strains at the species-level using molecular methods; (III) to determine their in vitro susceptibilities to commonly used antifungal agents; (IV) to compare the species diversity and the antifungal susceptibility profiles of the clinical and environmental isolates; (V) to compare the virulence of different clinical and environmental FSSC members; and (VI) to present and discuss the clinical details of the investigated keratomycosis cases.
Materials and Methods
Patients Specimens and Fusarium Isolates
A total of 22 Fusarium isolates derived from patients with keratomycoses attending the Aravind Eye Hospital and Postgraduate Institute of Ophthalmology (Coimbatore, Tamilnadu, India) along with 20 environmental FSSC isolates from the same region were investigated (Table 1). Corneal scrapings were performed by an ophthalmologist under strict aseptic conditions, on each base of the corneal ulcer using a Kimura's spatula after instillation of 4% preservative-free lidocaine. Materials obtained from scraping the leading edge and the base of the ulcers were inoculated directly onto 5% sheep blood agar, chocolate agar, potato dextrose agar (PDA) and into brain heart infusion broth without gentamicin sulfate (Himedia Laboratories, India). Sheep blood agar and chocolate agar plates were incubated at 37°C, while PDA plates and brain heart infusion bottles were incubated at 27°C for 3 weeks.
Table 1. Molecular identification and antifungal susceptibilities of Fusarium strains isolated from keratitis cases and environmental samples in South India.
To isolate fusaria from environmental sources, soil and plant parts (i.e., root and stem) were collected from gardens, parks, yards and agricultural fields in the surrounding regions of Coimbatore in November 2012. One gram of each collected soil sample was suspended in 10 ml sterile distilled water. The stock solutions were diluted 10 and 100 times and spread over Rose Bengal-Chloramphenicol agar (Himedia Laboratories, India) plates. The collected plant parts were pre-washed in sterile distilled water, surface-sterilized in 75% ethanol for 5 min and in 95% ethanol for 5 min, then rinsed in sterile distilled water for three times to remove ethanol residues. The sterilized parts were cut into small pieces, placed on Rose Bengal-Chloramphenicol agar plates and incubated at 25°C for 72 h. All fungal colonies from Rose Bengal-Chloramphenicol agar were subcultured into PDA plates using the cross-streak method. Then Fusarium-like colonies were purified and identified by macro- and microscopic characteristics. From both clinical and environmental samples, the purified fungal colonies were sub-cultured and stored on PDA plates at 4°C until further investigations.
Isolates suspected to be Fusarium sp. based on their macromorphological characteristics and microscopic features were further subjected to molecular identification. All isolates were grown in Potato Dextrose Broth (Sigma-Aldrich, USA) at 25°C in a shaker (New Brunswick Scientific Co., Inc., USA) at 220 rpm for 5 days, and subsequently genomic DNA was extracted with the MasterPure Yeast DNA Purification Kit (Epicentre Biotechnologies, USA) in accordance with manufacturer's instructions. FSSC isolates were selected using the FSSC-specific PCR as described by He et al. (2011) and confirmed with an EcoRI digestion-based PCR-RFLP method (Homa et al., 2013). For the species-level identification of FSSC-positive isolates, the 5′ portions of translation elongation factor 1α (TEF1) coding region and introns were amplified (O'Donnell et al., 1998). After Sanger sequencing (LGC Genomics GmbH, Germany) the TEF1 sequences were deposited in the GenBank (https://www.ncbi.nlm.nih.gov/nucleotide/) under the accession numbers listed in Table 1 and used as BLAST (Altschul et al., 1990) queries against the Fusarium MLST database (http://www.westerdijkinstitute.nl/fusarium/) (O'Donnell et al., 2010).
All the confirmed isolates were deposited in the Szeged Microbiological Collection (SZMC; http://szmc.hu/; http://www.wfcc.info/ccinfo/collection/by_id/987) under the strain numbers listed in Table 1.
Besides the FSSC strains isolated from clinical and environmental sources, two clinical members of the F. dimerum species complex (SZMC 11496 and SZMC 11540) were involved in the analysis as an outgroup. The sequences were aligned by Muscle v3.8.31 (Edgar, 2004) and manually refined in BioEdit v22.214.171.124 (Hall, 1999). Substitution models for the final alignment were selected by the AICc function in jModelTest 2.1.10 (Posada, 2008). Trees were inferred by Maximum Likelihood (ML) and Bayesian MCMC approaches. ML bootstrapping was performed in PhyML 3.0 under the TrN+G model of sequence evolution, using the nearest-neighbor interchange branch swapping algorithm and 1000 replicates of non-parametric bootstrap analysis (Guindon and Gascuel, 2003). ML bootstrap values >69% were considered as significant support (Soltis and Soltis, 2003). Bayesian MCMC analyses were run in MrBayes 3.1.2 (Huelsenbeck and Ronquist, 2001). One cold and three incrementally heated chains were run in two replicates sampling every 100th generation. Chain length was set to 10,000,000 generations and a burn-in value of 100 000 generations was chosen using the Tracer 1.4 software (Rambaut and Drummond, 2007). Post-burn-in trees were summarized in a 50% majority rule consensus tree in MrBayes. Posterior probabilities >0.94 were considered as significant.
Antifungal Susceptibility Tests
Antifungal susceptibility tests were performed as described in the Clinical and Laboratory Standards Institute (CLSI) M38-A2 broth microdilution method (Clinical Laboratory Standards Institute, 2008). Pharma grade powders of amphotericin B (AMB), clotrimazole (CLT), econazole (ECN), fluconazole (FLC), itraconazole (ITC), ketoconazole (KTC), terbinafine (TRB) (Sigma-Aldrich, USA), and commercially available natamycin (NTM) eye drops (Lalitha et al., 2008a) (Natamet, 5% suspension, Sun Pharmaceutical Ind. Ltd., India) were included in the tests. Conidial suspensions were prepared in 0.85% saline solution from 5-day-old cultures grown on PDA plates and diluted in RPMI-1640 medium (Sigma-Aldrich, USA) adjusting the final inoculum density to 104 CFU/ml. Fungal growth was evaluated after incubation for 48 h at 35°C without shaking. Minimal inhibitory concentration (MIC) was determined as the lowest concentration of an antifungal agent that inhibited completely the growth of the tested isolates compared to the drug-free control medium. For FLC and KTC, the MICs were defined as the lowest concentrations of the drugs that cause approximately 50% reduction in growth. MIC50 was determined as the MIC inhibiting the growth of 50% of all the tested isolates. Aspergillus flavus ATCC 204304 and Candida krusei ATCC 6258 were included as quality control strains. Each experiment was performed in triplicates.
Survival Experiments in Drosophila Melanogaster
To examine the background of F. falciforme dominance in South Indian human keratomycosis cases, the virulence of six FSSC isolates, i.e., F. falciforme SZMC 11407, SZMC 11408, and SZMC 21332, F. keratoplasticum SZMC 11414 and SZMC 21330, and F. solani s. str. SZMC 21348 was examined in D. melanogaster.
Conidial suspensions were prepared with sterile phosphate buffer saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4) from 5-day-old cultures grown on PDA plates at 35°C. The final inoculum densities were adjusted to 1 × 107 conidia/ml with PBS.
Drosophila stocks were raised and kept following the infection on standard cornmeal agar medium at 25°C. The Oregon R strain, originally obtained from the Bloomington stock center, was used as the wild type throughout the experiments. MyD88c03881 flies having impaired immune responses were described previously (Tauszig-Delamasure et al., 2002). Infection was performed by dipping a thin needle in a suspension of fungal conidia (107 conidia/ml) or PBS for the uninfected control, and subsequently the thorax of the anesthetized fly was pricked. Flies were counted at different points of time to monitor survival. Flies were moved into fresh vials every other day. Each experiment was performed with approximately 60 flies for each genotype. The results shown in Figure 1 are representative of at least three independent experiments.
Figure 1. Survival rates of wild-type (Oregon) and MyD88c03881 mutant flies infected with clinical F. falciforme SZMC 11407 and SZMC 11408 (A,B), clinical F. keratoplasticum SZMC 11414 (C), environmental F. keratoplasticum SZMC 21330 (D), environmental F. falciforme SZMC 21332 (E), and environmental F. solani s. str. SZMC 21348 (F) strains. The control groups were injected with sterile PBS.
All statistical analyses were performed in SigmaPlot (version 14.0). Two sample t-test was used to reveal significant differences between the antifungal susceptibility profiles of clinical and environmental isolates. Fisher's exact test was applied to compare the species composition of clinical and environmental isolates. Kaplan-Meier survival curves were generated in order to present the results of the survival experiments in D. melanogaster. The Log-Rank statistic was used to decide whether there is a statistically significant difference between the curves. To identify the group—or groups—of flies that differ from the others, the Holm-Sidak multiple comparison procedure was applied (Glantz, 2012). Significance level was set at p < 0.05.
Due to its observational nature, no formal ethics approval was required for this study. In order to protect the patients' anonymity, identifying information were not included in the manuscript.
Clinical Characteristics of Patients With Fusarium Keratitis
Clinical data are available for all cases but one (Strain No. SZMC 11425) (Table 2). Out of the 22 keratitis isolates, 20 were isolated from patients residing in Tamilnadu, while the rest were from Kerala. Majority of the infections (n = 13) were registered between June and August. None of the patients had any underlying conditions. Half of the patients reported trauma as a predisposing factor, while 10 patients could not recall any injury prior to the infection. The severity of the ulcer was recorded as mild in six, moderate in seven and severe in eight cases. The most common therapeutic approach was the combined topical application of NTM, ITC, and ECN eye drops (n = 16), which were supplemented with systemic KTC in 12 cases. Surgical intervention (therapeutic penetrating keratoplasty, TPK) was needed in four severe cases, where the topical and systemic drugs could not improve the patients' condition. The registered final outcomes were as follows: 16 patients were healed completely; the therapy failed in five cases and one patient was lost to follow-up.
Identification of the Fusarium Isolates Based on Molecular Markers
BLAST searches with the partial TEF1 sequences revealed that most of the isolates derived from both human keratomycoses and the environment belong to F. falciforme (n = 41; FSSC 3 + 4, O'Donnell et al., 2008). A clinical (SZMC 11414) and an environmental (SZMC 21330) isolate were identified as F. keratoplasticum (FSSC 2, Short et al., 2013), while another isolate from soil (SZMC 21348) was confirmed as F. solani s. str. (FSSC 5, Schroers et al., 2016; Table 1). Statistically significant association between the investigated FSSC species and their source was not detected. In order to examine the phylogenetic distribution of the isolates, a phylogenetic reconstruction was also performed using the above-mentioned TEF1 locus, which confirmed the BLAST-based identifications (Figure 2).
Figure 2. Combined phylogenetic tree based on the partial sequences of translation elongation factor 1α genes of clinical (indicated with black letters) and environmental (indicated with green letters) FSSC isolates. Only Bayesian posterior probability and ML bootstrap support values >0.95 and 60% are shown at the nodes.
Table 1 summarizes the MIC values of the eight investigated antifungal agents. Clinical and environmental strains showed similar susceptibilities. However, environmental isolates proved to be significantly (p = 0.01) less susceptible to ECN than the clinical FSSC isolates. In all other cases, statistically significant differences were not detected between these two populations. The lowest MICs were recorded for AMB and ECN (0.25–16 μg/ml). MIC values of CLT and NTM were between 2 and 16 μg/ml, while the activities of TRB and KTC varied in the MIC ranges of 0.5–64 and 2–64 μg/ml, respectively. ITC and FLC proved to be ineffective in the tested concentration ranges.
In the case of wild type Oregon flies, the clinical F. falciforme strains SZMC 11407 and SZMC 11408 and the environmental FSSC 5 strain SZMC 21348 proved to be avirulent; the survival rates 6 days post infection (dpi) were 79 ± 21%, 76 ± 6%, and 61 ± 15% (Figures 1A,B,F). At the same time, infection with the F. keratoplasticum strains SZMC 11414 and SZMC 21330 and the environmental F. falciforme strain SZMC 21332 resulted in a significant reduction in the survival rate compared to the control group, the 6 dpi survival rates were 33 ± 18%, 46 ± 12%, and 46 ± 23% (Figures 1C–E), respectively. All six tested strains reduced the 6 dpi survival rates of the MyD88-mutant MyD88c03881 flies to 4–15% (Figures 1A–F).
The population of tropical/subtropical countries such as India is more prone to eye infections, especially to fungal keratitis caused by Fusarium spp. generally due to the climatic conditions. Regular monitoring of the disease is essential for its effective management (Lalitha et al., 2008b; Kredics et al., 2015).
As it is shown in Table 2, we found the highest incidence of FSSC keratitis cases in July. Previously, Lin et al. (2012) also observed an uneven distribution of Fusarium keratitis cases throughout the year in South India with a major peak of registered cases in July. This peak was associated with the windy season in June-July, when dust particles are presumed to be the main causes of ocular trauma (Lin et al., 2012). This theory is reinforced by the clinical records summarized in Table 2, where dust was mentioned as a predisposing factor for the infection only in June and July. A minor peak of keratitis cases in January—which was detected by Lin et al. (2012) and was attributed to the intensive agricultural activities of the harvest season resulting in elevated concentrations of conidia in the air and frequent ocular injuries due to soil or plant debris particles—was not observed in our study. Interestingly, Lin et al. (2012) also observed that environmental humidity (dry and wet season) was not a significant factor in the seasonal patterns of fungal keratitis.
We observed some major variations especially in the risk factors and treatment of Fusarium keratitis cases when compared our data with the study of Walther et al. (2017) from Germany. Based on the clinical details, trauma was the most frequently recorded predisposing factor for Fusarium keratitis in India (Bharathi et al., 2007; Tupaki-Sreepurna et al., 2017a), whereas keratomycoses were rare in temperate climates and more commonly associated with the use of soft contact lenses (Keay et al., 2011; Walther et al., 2017). As shown in Table 2, most of the patients at the Aravind Eye Hospital were treated with the topical applications of NTM, ECN and ITC along with systemic KTC, while in Germany, AMB and VRC were the most frequently used antifungals not just in topical, but also in invasive and systemic therapeutic approaches. Surgical intervention was performed in four out of the 21 cases in the present study, while Walther et al. (2017) reported that nine out of 15 cases required TPK. Despite the differing therapeutic approaches, comparing the outcomes we could not find any differences between the two investigations; therapeutic failures were reported 3/15 times (20.0%) by Walther et al. (2017) and 5/21 times (23.8%) in the present study.
Several papers reported that Fusarium species—particularly members of the FSSC—are the predominant etiological agents of keratomycosis (Table 3). However, based on the English language literature available in the PubMed (http://www.ncbi.nlm.nih.gov/pubmed) and Google Scholar (https://scholar.google.hu/) databases, species level identification is still not a common practice with Fusarium keratitis cases. In South India, F. falciforme proved to be the most common FSSC species followed by F. keratoplasticum (Homa et al., 2013; Hassan et al., 2016; Tupaki-Sreepurna et al., 2017a,b). These results were similar to those observed in the present study (Table 1). In the work of Tupaki-Sreepurna et al. (2017a), seven out of nine isolates were F. keratoplasticum, and the remaining two were identified as F. falciforme. This difference in the frequency of the two species could be explained by the small sample size. In contrast to these data from India, in Hong Kong and Singapore F. keratoplasticum, while in the USA, F. petroliphilum, F. keratoplasticum and F. falciforme were isolated from Fusarium keratitis cases. All of these species were identified in 2005 and 2006 during the multistate Fusarium keratitis outbreak associated with the use of Bausch and Lomb ReNu contact lens solution (Chang et al., 2006). Finally, in Germany F. petroliphilum and F. keratoplasticum, while in Turkey F. solani s. str. dominated among Fusarium keratitis isolates (Dalyan et al., 2015; Walther et al., 2017). Fusarium lichenicola was not isolated either from the environment or from clinical specimens in our study. According to our literature overview of Fusarium keratitis studies in Table 3, it is obvious that this species is an extremely rare causative agent of this disease. Previously, only Hassan et al. (2016) reported a single F. lichenicola isolate from keratomycosis from the Aravind Eye Hospital in Coimbatore, Tamilnadu.
Although our phylogeny (Figure 2) has been inferred using only the partial TEF1 gene, it could be used to identify the isolates tested. TEF1 is widely used to investigate the phylogenetic relationships of fusaria at the interspecific level (Debourgogne et al., 2012), but this locus alone is not appropriate to examine intraspecies relationships. According to O'Donnell et al. (2015), TEF1 and the largest (RPB1) and the second largest subunit (RPB2) of the DNA-directed RNA polymerase II are the three most informative loci for phylogenetic species recognition in the genus Fusarium. Multilocus sequence typing (MLST) schemes including additional loci, e.g., the beta-tubulin gene, the internal transcribed spacer (ITS) region and the large ribosomal subunit gene (LSU) have also been proposed for fusaria (van Diepeningen et al., 2015). As it was previously described by Zhang et al. (2006) based on the phylogenetic analysis of the FSSC, we also found that clinical and environmental members of this species complex share a common evolutionary origin.
Susceptibility data on fusaria were not congruent in the literature (Table 4). According to Walther et al. (2017), FSSC and non-FSSC isolates may be easily separated based on their in vitro susceptibility to TRB. In their study, FSSC showed MICs higher than 32 μg/ml, while FOSC (F. oxysporum species complex) and FFSC (F. fujikuroi species complex) strains had MICs lower than 8 μg/ml (Walther et al., 2017). Our MIC data for the FSSC isolates did not confirm this suggestion; we observed a wide range of MICs for TRB (0.5–64 μg/ml). However, there are two fundamental differences between these reports: the geographical location and the species diversity. In contrast to the study of Walther et al. (2017), where F. petroliphilum and F. keratoplasticum were the most prevalent among the FSSC isolates, most of the strains in the present study were identified as F. falciforme.
Table 4. Literature overview of antifungal susceptibility data available for FSSC strains isolated from human keratomycoses.
In contrast to the currently reported susceptibility results, one of our previous studies revealed higher MIC values for all the tested antifungal drugs (Homa et al., 2013). However, in another South Indian keratitis study, Shobana et al. (2015) reported lower azole MICs (especially for ITC) for fusaria. According to Al-Hatmi et al. (2016), Fusarium spp. were intrinsically resistant to azoles. In agreement with this finding, we also found that ITC and FLC did not inhibit the growth of the investigated strains.
Triazole fungicides (i.e., hexaconazole, propiconazole, triadimefon, and tricyclazole) are commonly used for crop protection in India, especially in the Southern parts of the country (Chowdhary et al., 2012). The high exposure of environmental fungi to these compounds persisting in soil for a long time, may increase the risk of resistance development. For instance, the azole resistance of the common opportunistic human pathogen Aspergillus fumigatus was attributed to the non-medical use of these antifungals in the past few years (Van der Linden et al., 2011; Chowdhary et al., 2013; Azevedo et al., 2015; Berger et al., 2017). Although fusaria have not yet been investigated in this respect, we presume that resistance might emerge among them as a result of the permanent presence of fungicides in the environment.
When comparing our antifungal susceptibility data with previous studies, we also found similarities (Table 4). AMB and ECN were the most effective antifungal drugs against the majority of our isolates. Similarly, AMB showed the lowest MICs in other studies (Dalyan et al., 2015; Hassan et al., 2016; Walther et al., 2017). In accordance with the literature, all the MICs of NTM in our study were ≤16 μg/ml (Hassan et al., 2016; Tupaki-Sreepurna et al., 2017a; Walther et al., 2017), which is probably within the clinically achievable levels of this drug in eye tissue (Lalitha et al., 2008a).
Although species-specific clinical breakpoints are still not available for the genus Fusarium, CLSI epidemiological cutoff values (ECVs) were reported by Espinel-Ingroff et al. (2016) for AMB, posaconazole, voriconazole and ITC. These values may not able to help in predicting the clinical response to therapy but could possibly help to identify the so-called “non-wild-type isolates” or isolates that are less susceptible to the antifungal drugs. The authors defined “non-wild-type” as the population of strains in a species-drug combination with a detectable acquired resistance mechanism (Espinel-Ingroff et al., 2016). The ECVs for AMB and ITC are 8 μg/ml and 32 μg/ml, respectively. Based on these values, our isolates proved to be less susceptible to ITC (MIC > 32 μg/ml) than wild-type FSSC strains. At the same time, the MICs of AMB were below the ECV (Table 1).
Drosophila melanogaster has been previously described as a suitable invertebrate host model to study the in vivo virulence and pathogenesis of clinically important filamentous fungi (i.e., Aspergillus spp., Mucorales spp., Scedosporium spp. and Fusarium spp.) (Hamilos et al., 2012). This fly has a genetically tractable and well-characterized innate immune system, which is regulated by two distinct signaling pathways: the immune deficiency and the Toll pathways. While the first one is important in the defense against Gram-negative bacteria, the latter one has a key role in the immunity against Gram-positive bacteria and fungi (Lemaitre and Hoffmann, 2007). MyD88 is an adapter in the Toll pathway and its overexpression induces the expression of the antifungal peptide drosomycin (Tauszig-Delamasure et al., 2002).
Previously, Lamaris et al. (2007) infected wild-type Oregon and Toll-deficient flies with a clinical F. verticillioides (formerly F. moniliforme, a member of the FFSC) strain. Both wild-type and mutant flies were susceptible to this fungus, but in Toll-deficient flies a more acute infection and higher mortality rates were observed (Lamaris et al., 2007). As it was expected, we also found lower survival rates in case of the MyD88-mutants than the wild-type flies. Our results reconfirmed that MyD88 was essential for D. melanogaster to recognize and eliminate fusaria.
Although D. melanogaster proved to be highly susceptible to F. keratoplasticum (Figure 1) in our study, intraspecies differences in the virulence of F. falciforme isolates suggest that virulence is more like a strain-specific, than a species-specific feature. These results were in agreement with the hypothesis of Zhang et al. (2006), namely, that susceptible patients are infected with the most prevalent fungi in their environment.
In conclusion, our results confirmed that F. falciforme was the most prevalent species of the FSSC in South India isolated from both Fusarium keratitis patients and environmental sources. Antifungal susceptibility and virulence of clinical and environmental isolates were similar. However, we found major differences in the most common etiological agents, compared to North-American, European and other Asian countries. In the consequences of the high incidence of Fusarium keratitis and the significant rate of treatment failure, regular clinical studies are still necessary to develop an effective management of this disease in South India.
TP: contributed to the design and implementation of the research, participated in drafting the manuscript; LK, VN, and CV: contributed to analyze the results and helped in drafting the manuscript; LG: participated in molecular identification and the antifungal susceptibility tests; PM: collected all the clinical data reported in the manuscript and participated in the morphological identification process; RS and ÁC: performed the virulence studies; MH: performed the antifungal susceptibility tests, drafted the manuscript and designed the figures and the tables. All authors read and approved the final manuscript.
This study was supported by the Lendület Grant of the Hungarian Academy of Sciences (LP2016-8/2016) and the project GINOP-2.3.2-15-2016-00035. LG is financed from the Postdoctoral Excellence Programme (PD 120808) and the bilateral Austrian-Hungarian Joint Research Project (ANN 122833) of the Hungarian National Research, Development and Innovation Office (NKFI Office). LK is grantee of the János Bolyai Research Scholarship (Hungarian Academy of Sciences). The authors of this study were also supported by the Indian National Science Academy and the Hungarian Academy of Sciences within the framework of the INSA-HAS Indo-Hungarian bilateral exchange program (SNK-49/2013).
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Azevedo, M. M., Faria-Ramos, I., Cruz, L. C., Pina-Vaz, C., and Rodrigues, A. G. (2015). Genesis of azole antifungal resistance from agriculture to clinical settings. J. Agric. Food Chem. 63, 7463–7468. doi: 10.1021/acs.jafc.5b02728
Azor, M., Gené, J., Cano, J., and Guarro, J. (2007). Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex. Antimicrob. Agents Chemother. 51, 1500–1503. doi: 10.1128/AAC.01618-06
Bacon, C. W., and Yates, I. E. (2006). “Endophytic root colonization by Fusarium species: histology, plant interactions, and toxicity,” in Microbial Root Endophytes, eds B. J. E. Schulz, C. J. C. Boyle, and T. N. Sieber (Heidelberg: Springer), 133–152.
Berger, S., El Chazli, Y., Babu, A. F., and Coste, A. T. (2017). Azole resistance in Aspergillus fumigatus: a consequence of antifungal use in agriculture? Front. Microbiol. 8:1024. doi: 10.3389/fmicb.2017.01024
Bharathi, M. J., Ramakrishnan, R., Meenakshi, R., Padmavathy, S., Shivakumar, C., and Srinivasan, M. (2007). Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic. Epidemiol. 14, 61–69. doi: 10.1080/09286580601001347
Chang, D. S., Grant, G. B., O'Donnell, K., Wannemuehler, K. A., Noble-Wang, J. C. Y., Jacobson, L. M., et al. (2006). Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. J. Am. Med. Assoc. 296, 953–963. doi: 10.1001/jama.296.8.953
Chowdhary, A., Kathuria, S., Xu, J., and Meis, J. F. (2013). Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog. 9:e1003633. doi: 10.1371/journal.ppat.1003633
Chowdhary, A., Kathuria, S., Xu, J., Sharma, C., Sundar, G., Singh, P. K., et al. (2012). Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR34/L98H mutations in the cyp51A gene in India. PLoS ONE 7:e52871. doi: 10.1371/journal.pone.0052871
Clinical and Laboratory Standards Institute (2008). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard-Second Edition. CLSI Document M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute.
Dalyan, C. B., Al-Hatmi, A. M., Seyedmousavi, S., Rijs, A. J., Verweij, P. E., Ener, B., et al. (2015). Emergence of fusarioses in a university hospital in Turkey during a 20-year period. Eur. J. Clin. Microbiol. Infect. Dis. 34, 1683–1691. doi: 10.1007/s10096-015-2405-y
Dean, R., Van Kan, J. A., Pretorius, Z. A., Hammond-Kosack, K. E., Di Pietro, A., Spanu, P. D., et al. (2012). The top 10 fungal pathogens in molecular plant pathology. Mol. Plant Pathol. 13, 414–430. doi: 10.1111/j.1364-3703.2011.00783.x
Debourgogne, A., Gueidan, C., de Hoog, S., Lozniewski, A., and Machouart, M. (2012). Comparison of two DNA sequence-based typing schemes for the Fusarium solani species complex and proposal of a new consensus method. J. Microbiol. Methods 91, 65–72. doi: 10.1016/j.mimet.2012.07.012
Espinel-Ingroff, A., Colombo, A. L., Cordoba, S., Dufresne, P. J., Fuller, J., Ghannoum, M., et al. (2016). An international evaluation of MIC distributions and ECV definition for Fusarium species identified by molecular methods for the CLSI broth microdilution method. Antimicrob. Agents. Chemother. 60, 1079–1084. doi: 10.1128/AAC.02456-15
Geiser, D. M., Aoki, T., Bacon, C. W., Baker, S. E., Bhattacharyya, M. K., Brandt, M. E., et al. (2013). One fungus, one name: defining the genus Fusarium in a scientifically robust way that preserves longstanding use. Phytopathology 103, 400–408. doi: 10.1094/PHYTO-07-12-0150-LE
Gräfenhan, T., Schroers, H. J., Nirenberg, H. I., and Seifert, K. A. (2011). An overview of the taxonomy, phylogeny, and typification of nectriaceous fungi in Cosmospora, Acremonium, Fusarium, Stilbella, and Volutella. Stud. Mycol. 68, 79–113. doi: 10.3114/sim.2011.68.04
Hamilos, G., Samonis, G., and Kontoyiannis, D. P. (2012). Recent advances in the use of Drosophila melanogaster as a model to study immunopathogenesis of medically important filamentous fungi. Int. J. Microbiol. 2012:583792. doi: 10.1155/2012/583792
Hassan, A. S., Al-Hatmi, A. M., Shobana, C. S., van Diepeningen, A. D., Kredics, L., Vágvölgyi, C., et al. (2016). Antifungal susceptibility and phylogeny of opportunistic members of the genus Fusarium causing human keratomycosis in South India. Med. Mycol. 54, 287–294. doi: 10.1093/mmy/myv105
Hawksworth, D. L., Crous, P. W., Redhead, S. A., Reynolds, D. R., Samson, R. A., Seifert, K. A., et al. (2011). The Amsterdam declaration on fungal nomenclature. IMA Fungus. 2, 105–112. doi: 10.5598/imafungus.2011.02.01.14
He, D., Hao, J., Zhang, B., Yang, Y., Song, W., Zhang, Y., et al. (2011). Pathogenic spectrum of fungal keratitis and specific identification of Fusarium solani. Invest. Ophthalmol. Vis. Sci. 52, 2804–2808. doi: 10.1167/iovs.10-5977
Homa, M., Shobana, C. S., Singh, Y. R., Manikandan, P., Selvam, K. P., Kredics, L., et al. (2013). Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex. Mycoses 56, 501–511. doi: 10.1111/myc.12062
Keay, L. J., Gower, E. W., Iovieno, A., Oechsler, R. A., Alfonso, E. C., Matoba, A., et al. (2011). Clinical and microbiological characteristics of fungal keratitis in the United States, 2001-2007: a multicenter study. Ophthalmology 118, 920–926. doi: 10.1016/j.ophtha.2010.09.011
Kredics, L., Narendran, V., Shobana, C. S., Vágvölgyi, C., Manikandan, P., et al. (2015). Filamentous fungal infections of the cornea: a global overview of epidemiology and drug sensitivity. Mycoses 58, 243–260. doi: 10.1111/myc.12306
Lalitha, P., Vijaykumar, R., Prajna, N. V., and Fothergill, A. W. (2008a). In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder. J. Clin. Microbiol. 46, 3477–3478. doi: 10.1128/JCM.00610-08
Lalitha, P., Vijaykumar, R., Prajna, N. V., and Srinisvasan, M. (2008b). Aravind's Atlas of Fungal Corneal Ulcers-Clinical Features and Laboratory Identification Methods. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd.
Lamaris, G. A., Chamilos, G., Lewis, R. E., and Kontoyiannis, D. P. (2007). Virulence studies of Scedosporium and Fusarium species in Drosophila melanogaster. J. Infect. Dis. 196, 1860–1864. doi: 10.1086/523765
Lin, C. C., Prajna, L., Srinivasan, M., Prajna, N. V., McLeod, S. D., Acharya, N. R., et al. (2012). Seasonal trends of microbial keratitis in south India. Cornea 31, 1123–1127. doi: 10.1097/ICO.0b013e31825694d3
O'Donnell, K., Ward, T. J., Robert, V. A. R. G., Crous, P. W., Geiser, D. M., and Kang, S. (2015). DNA sequence-based identification of Fusarium: current status and future directions. Phytoparasitica. 43, 583–595. doi: 10.1007/s12600-015-0484-z
O'Donnell, K., Kistler, H. C., Cigelnik, E., and Ploetz, R. C. (1998). Multiple evolutionary origins of the fungus causing Panama disease of banana: concordant evidence from nuclear and mitochondrial gene genealogies. Proc. Natl. Acad. Sci. U.S.A. 95, 2044–2049. doi: 10.1073/pnas.95.5.2044
O'Donnell, K., Rooney, A. P., Proctor, R. H., Brown, D. W., McCormick, S. P., Ward, T. J., et al. (2013). Phylogenetic analyses of RPB1 and RPB2 support a middle Cretaceous origin for a clade comprising all agriculturally and medically important fusaria. Fungal. Genet. Biol. 52, 20–31. doi: 10.1016/j.fgb.2012.12.004
O'Donnell, K., Sutton, D. A., Fothergill, A., McCarthy, D., Rinaldi, M. G., Brandt, M. E., et al. (2008). Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol. 46, 2477–2490. doi: 10.1128/JCM.02371-07
O'Donnell, K., Sutton, D. A., Rinaldi, M. G., Sarver, B. A., Balajee, S. A., Schroers, H. J., et al. (2010). Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol. 48, 3708–3718. doi: 10.1128/JCM.00989-10
Rambaut, A., and Drummond, A. J. (2007). MCMC Trace Analysis Tool Version v1.4. Available online at: http://tree.bio.ed.ac.uk/software/tracer/.
Schroers, H. J., Samuels, G. J., Zhang, N., Short, D. P., Juba, J., and Geiser, D. M. (2016). Epitypification of Fusisporium (Fusarium) solani and its assignment to a common phylogenetic species in the Fusarium solani species complex. Mycologia 108, 806–819. doi: 10.3852/15-255
Shobana, C. S., Mythili, A., Homa, M., Galgóczy, L., Priya, R., Babu Singh, Y. R., et al. (2015). In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs. J. Mycol. Med. 25, 44–49. doi: 10.1016/j.mycmed.2014.10.024
Short, D. P., O'Donnell, K., Thrane, U., Nielsen, K. F., Zhang, N., Juba, J. H., et al. (2013). Phylogenetic relationships among members of the Fusarium solani species complex in human infections and the descriptions of F. keratoplasticum sp. nov. and F. petroliphilum stat. nov. Fungal Genet. Biol. 53, 59–70. doi: 10.1016/j.fgb.2013.01.004
Short, D. P., O'Donnell, K., Zhang, N., Juba, J. H., and Geiser, D. M. (2011). Widespread occurrence of diverse human pathogenic types of the fungus Fusarium detected in plumbing drains. J. Clin. Microbiol. 49, 4264–4272. doi: 10.1128/JCM.05468-11
Sun, S., Lyu, Q., Han, L., Ma, Q., Hu, H., He, S., et al. (2015). Molecular identification and in vitro susceptibility of Fusarium from fungal keratitis in central China. Zhonghua. Yan. Ke. Za. Zhi. 51, 660–667.
Tauszig-Delamasure, S., Bilak, H., Capovilla, M., Hoffmann, J. A., and Imler, J. L. (2002). Drosophila MyD88 is required for the response to fungal and Gram-positive bacterial infections. Nat. Immunol. 3, 91–97. doi: 10.1038/ni747
Tupaki-Sreepurna, A., Al-Hatmi, A. M. S., Kindo, A. J., Sundaram, M., and de Hoog, G. S. (2017a). Multidrug-resistant Fusarium in keratitis: a clinico-mycological study of keratitis infections in Chennai, India. Mycoses 60, 230–233. doi: 10.1111/myc.12578
Tupaki-Sreepurna, A., Thanneru, V., Sharma, S., Hemanth, B., Gopi, A., Sathyamoorthy, S., et al. (2017b). Multilocus sequence typing and phylogenetic analysis of clinical Fusarium strains isolated from South India. Mycoses. 60, 42–43. doi: 10.1111/myc.12673
Van der Linden, J. W. M., Snelders, E., Kampinga, G. A., Rijnders, B. J. A., Mattsson, E., Debets-Ossenkopp, Y. J., et al. (2011). Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007-2009. Emerg. Infect. Dis. 17, 1846–1854. doi: 10.3201/eid1710.110226
van Diepeningen, A. D., Al-Hatmi, A. M. S., Brankovics, B., and de Hoog, G. S. (2014). Taxonomy and clinical spectra of Fusarium species: where do we stand in 2014? Curr. Clin. Microbiol. Rep. 1, 10–18. doi: 10.1007/s40588-014-0003-x
van Diepeningen, A. D., Brankovics, B., Iltes, J., van der Lee, T. A., and Waalwijk, C. (2015). Diagnosis of Fusarium infections: approaches to identification by the clinical mycology laboratory. Curr. Fungal. Infect. Rep. 9, 135–143. doi: 10.1007/s12281-015-0225-2
Zhang, N., O'Donnell, K., Sutton, D. A., Nalim, F. A., Summerbell, R. C., Padhye, A. A., et al. (2006). Members of the Fusarium solani species complex that cause infections in both humans and plants are common in the environment. J. Clin. Microbiol. 44, 2186–2190. doi: 10.1128/JCM.00120-06
Keywords: keratomycosis, Fusarium solani species complex, F. falciforme, molecular identification, antifungal susceptibility, Drosophila melanogaster, virulence
Citation: Homa M, Galgóczy L, Manikandan P, Narendran V, Sinka R, Csernetics Á, Vágvölgyi C, Kredics L and Papp T (2018) South Indian Isolates of the Fusarium solani Species Complex From Clinical and Environmental Samples: Identification, Antifungal Susceptibilities, and Virulence. Front. Microbiol. 9:1052. doi: 10.3389/fmicb.2018.01052
Received: 09 February 2018; Accepted: 03 May 2018;
Published: 23 May 2018.
Edited by:Leo Van Overbeek, Wageningen University & Research, Netherlands
Reviewed by:Macit Ilkit, Çukurova University, Turkey
Jason Sahl, Northern Arizona University, United States
Anne D. Van Diepeningen, Fungal Biodiversity Centre (KNAW), Netherlands
Copyright © 2018 Homa, Galgóczy, Manikandan, Narendran, Sinka, Csernetics, Vágvölgyi, Kredics and Papp. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tamás Papp, firstname.lastname@example.org